Skip to main content

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

PRTK holding history

Paratek Pharmaceuticals, Inc. in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PRTK overviewAll 13F holders of PRTKFull Q2 2026 holdings

Shares (Q3 2023)
0
Sold out in Q3 2023
Value
$0
% of portfolio
0.0%
Quarters held
10
Since Q1 2021
Holdings of PRTK by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20230$00.0%−53,000−100.0%Sold outHolders
Q2 202353,000$117.0K<0.1%+20,000+60.6%AddedHolders
Q1 202333,000$84.0K<0.1%00.0%UnchangedHolders
Q4 202233,000$62.0K<0.1%00.0%UnchangedHolders
Q3 202233,000$85.0K<0.1%00.0%UnchangedHolders
Q2 202233,000$64.0K<0.1%+8,500+34.7%AddedHolders
Q1 202224,500$72.0K<0.1%00.0%UnchangedHolders
Q4 202124,500$110.0K<0.1%00.0%UnchangedHolders
Q3 202124,500$119.0K<0.1%00.0%UnchangedHolders
Q2 202124,500$167.0K<0.1%+9,000+58.1%AddedHolders
Q1 202115,500$110.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.